Health News
Too Much of a Good Thing
Though many people are deficient in vitamin D, it's possible to go too far to make up the difference. The "sunshine vitamin" may only protect the heart if you have the right amount.
Risks of a Life-Saving Surgery for Women
Women at risk of ovarian cancer are sometimes encouraged to get their ovaries removed. While ovary removal surgery can save a woman's life, it also may raise the risk of other health problems.
Notifications Improve Osteoporosis Care
You've just gotten out of the hospital after a major fracture. You want to avoid the experience again, but are you receiving care to prevent another fracture?
Yes, You Can Grow Stronger Bones
It's common for women to lose bone mass and density as they age. Women with extra weight around their bellies are at increased risk for osteoporosis. Can growth hormones help them?
Vibrating Doesn't Boost Bones Strength
Whole-body vibration training has taken off in gyms around the world. But a study has found that the vibrating platforms fail to meet claims of boosting bone health.
Osteoporosis Tool Approved
A diagnostic tool for early assessment of osteoporosis has gained FDA approval. The device, called Sunlight MiniOmni, is already used in Europe, Asia, and the Middle East.
Osteoporosis in the Middle East and Africa
A recent report released predicts a dramatic rise in osteoporotic bone fractures throughout Middle Eastern and African countries.
Get healthy on World Osteoporosis Day
Osteoporosis can touch everyone, regardless of race, gender, or national borders. That's why the International Osteoporosis Foundation marks World Osteoporosis Day on Thursday, October 20.
Osteoporosis More Widespread Than Previously Believed
It's no secret that millions suffer from osteoporosis. But new research suggests the disease and an early marker for developing it may be significantly more widespread than previously believed.
FDA Approves Prolia for osteoporosis
On September 16, 2011, the U.S. Food and Drug Administration granted approval for denosumab ( Prolia , Amgen Inc.) as a treatment to increase bone mass in patients at high risk for fracture receiving androgen deprivation therapy (ADT) for nonmetastatic prostate cancer or adjuvant aromatase inhibitor (AI) therapy for breast cancer. In men with nonmetastatic prostate cancer, denosumab also reduced the incidence of vertebral fracture.